BGC201531 (AP-1531) is a selective EP4 receptor antagonist developed for acute migraine research. It has demonstrated efficacy in preclinical models of migraine pain, supporting its investigation in both in vitro receptor studies and in vivo animal experiments related to inflammation and nociception.
Molekulargewicht:
496.58
Reinheit:
99.33% (May vary between batches)
CAS Nummer:
[1186532-61-5]
Formel:
C26H28N2O6S
Target-Kategorie:
PKA,Prostaglandin Receptor
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten